Annual Current Liabilities
$39.48 M
-$119.31 M-75.14%
December 1, 2024
Summary
- As of March 12, 2025, TRDA annual total current liabilities is $39.48 million, with the most recent change of -$119.31 million (-75.14%) on December 1, 2024.
- During the last 3 years, TRDA annual current liabilities has risen by +$32.76 million (+487.62%).
- TRDA annual current liabilities is now -75.14% below its all-time high of $158.80 million, reached on December 31, 2023.
Performance
TRDA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$39.48 M
-$31.12 M-44.08%
December 1, 2024
Summary
- As of March 12, 2025, TRDA quarterly total current liabilities is $39.48 million, with the most recent change of -$31.12 million (-44.08%) on December 1, 2024.
- Over the past year, TRDA quarterly current liabilities has stayed the same.
- TRDA quarterly current liabilities is now -77.30% below its all-time high of $173.94 million, reached on March 31, 2024.
Performance
TRDA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TRDA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -75.1% | 0.0% |
| 3 y3 years | +487.6% | +79.7% |
| 5 y5 years | +1955.3% | +79.7% |
TRDA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.1% | +487.6% | -77.3% | +487.6% |
| 5 y | 5-year | -75.1% | +1955.3% | -77.3% | +1075.4% |
| alltime | all time | -75.1% | +1955.3% | -77.3% | +1075.4% |
Entrada Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $39.48 M(-75.1%) | $39.48 M(-44.1%) |
| Sep 2024 | - | $70.60 M(-17.7%) |
| Jun 2024 | - | $85.81 M(-50.7%) |
| Mar 2024 | - | $173.94 M(+9.5%) |
| Dec 2023 | $158.80 M(+622.7%) | $158.80 M(-4.0%) |
| Sep 2023 | - | $165.43 M(+31.4%) |
| Jun 2023 | - | $125.94 M(-14.7%) |
| Mar 2023 | - | $147.59 M(+571.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $21.97 M(+227.0%) | $21.97 M(+2.0%) |
| Sep 2022 | - | $21.55 M(+19.2%) |
| Jun 2022 | - | $18.08 M(+17.2%) |
| Mar 2022 | - | $15.43 M(+129.6%) |
| Dec 2021 | $6.72 M(+100.0%) | $6.72 M(-6.1%) |
| Sep 2021 | - | $7.16 M(+57.8%) |
| Jun 2021 | - | $4.54 M(+35.0%) |
| Dec 2020 | $3.36 M(+74.9%) | $3.36 M |
| Dec 2019 | $1.92 M | - |
FAQ
- What is Entrada Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Entrada Therapeutics?
- What is Entrada Therapeutics annual current liabilities year-on-year change?
- What is Entrada Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly current liabilities year-on-year change?
What is Entrada Therapeutics annual total current liabilities?
The current annual current liabilities of TRDA is $39.48 M
What is the all time high annual current liabilities for Entrada Therapeutics?
Entrada Therapeutics all-time high annual total current liabilities is $158.80 M
What is Entrada Therapeutics annual current liabilities year-on-year change?
Over the past year, TRDA annual total current liabilities has changed by -$119.31 M (-75.14%)
What is Entrada Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TRDA is $39.48 M
What is the all time high quarterly current liabilities for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly total current liabilities is $173.94 M
What is Entrada Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TRDA quarterly total current liabilities has changed by $0.00 (0.00%)